UK Markets open in 8 hrs
NIKKEI 225
26,173.98 -397.89 (-1.50%) HANG SENG
17,250.88 -609.43 (-3.41%) CRUDE OIL
81.78 -0.37 (-0.45%) GOLD FUTURES
1,666.10 -3.90 (-0.23%) DOW
29,683.74 +548.75 (+1.88%) BTC-GBP
17,957.28 +299.54 (+1.70%)
Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 82.37 |
| Open | 82.71 |
| Bid | 83.80 x 1400 |
| Ask | 84.62 x 1100 |
| Day's range | 82.02 - 84.65 |
| 52-week range | 81.87 - 131.73 |
| Volume | |
| Avg. volume | 2,513,219 |
| Market cap | 52.594B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | 62.45 |
| EPS (TTM) | 1.35 |
| Earnings date | 25 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 119.65 |
- Zacks
Edwards Lifesciences (EW) Debuts SAPIEN 3 Ultra RESILIA Valve
Edwards Lifesciences' (EW) SAPIEN 3 Ultra RESILIA valve combines its breakthrough RESILIA tissue technology with the SAPIEN 3 Ultra transcatheter aortic heart valve.
- Simply Wall St.
Great week for Edwards Lifesciences Corporation (NYSE:EW) institutional investors after losing 20% over the previous year
To get a sense of who is truly in control of Edwards Lifesciences Corporation ( NYSE:EW ), it is important to...
- Zacks
Edward Lifesciences (EW) Gains From New Products Amid Cost Woe
Edwards Lifesciences (EW) expects full-year 2022 underlying sales to grow on the back of strength in demand for products used in more intense surgeries.
© 2022 Yahoo. All rights reserved.
